Skip to main content
. 2009 Oct 1;181(1):87–93. doi: 10.1164/rccm.200906-0981OC

TABLE 1.

DESCRIPTION OF ACID FAST BACILLI SMEAR-NEGATIVE ACTIVE TUBERCULOSIS SUSPECTS

Characteristic Total Noncases (n = 595) Culture-Positive Cases (n = 65) P Value
Age, years, median (IQR) 54 (43–64) 54 (44–65) 50 (36–62) 0.06
Male, % 61 61 69 0.17
Race/ethnicity, %
 White 6 6 9 0.38
 African American 6 6 8
 Asian 79 80 71
 Hispanic 9 8 12
US born, % 10 9 18 0.02
Positive QFT-G result*, % 55 52 72 <0.01
IFN-γ concentration, IU/ml, median (IQR) 0.46 (0.06–2.42) 0.37 (0.05–2.38) 1.1 (0.36–3.77) <0.01
Quintiles of IFN-γ concentration (IU/ml), %
 <0.04 22 6 <0.001
 0.04–0.23 20 9
 0.23–0.9 19 34
 0.9–3.12 20 22
 3.12–10 19 29
Active disease on CXR, % 19 16 43 <0.001
Clinical symptoms, %
 Night sweats or weight loss 17 15 32 <0.001
 Cough 29 28 35 0.20
 Hemoptysis 5 5 8 0.33
Previous active TB, % 15 16 5 0.01
Contact to active TB case, % 2 2 6 0.03
Predisposing medical condition, % 13 13 11 0.60
Homelessness, % 8 8 12 0.18
BCG vaccination, % 20 20 18 0.79
Diabetes mellitus, % 9 10 5 0.19
Clinician suspicion for active TB at initial evaluation, %
 Low 73 79 26 <0.001
 Intermediate 13 12 20
 High
14
9
54

Definition of abbreviations: BCG = bacillus Calmette-Guérin vaccine; CXR = chest radiograph; IQR = Interquartile range; QFT-G = QuantiFERON-TB Gold; TB = tuberculosis.

Values are percentages unless otherwise stated.

*

Positive at the manufacturer-recommended cut point of 0.35 IU/ml.

Predisposing medical condition: diabetes mellitus, silicosis, cancer, or condition requiring use of immunosuppressive medications.